1.Research on the anti-inflammatory effects of a novel sleep-aid decoction on elderly insomnia patients across traditional Chinese medicine constitutional types.
Zhen WU ; Zhuoqiong BIAN ; Ailin CHEN ; Qiuping ZHANG ; Jie LI ; Hui ZHOU ; Hongying ZHU
Chinese Journal of Cellular and Molecular Immunology 2025;41(11):1007-1012
Objective To evaluate the clinical efficacy of a novel sleep-aid decoction in treating elderly insomnia patients with different traditional Chinese medicine (TCM) constitutional types, and its effects on neurotransmitter and inflammatory factor levels. Methods A total of 200 patients with four different TCM constitutions-peaceful, Qi-deficient, Yin-deficient, and Yang-deficient-were recruited. Peripheral blood neurotransmitter and inflammatory factor levels were measured for variations among insomnia patients across different constitutions. These patients were treated using the novel sleep-aid decoction, the effects of which were evaluated based on changes in neurotransmitters and inflammatory factors. Results Compared to the peaceful constitution group, insomnia patients with Qi-deficient, Yin-deficient, and Yang-deficient constitutions exhibited significantly elevated baseline levels of neurotransmitters (5-HT, GABA) and inflammatory factors (IL-6, TNF-α, IL-1β, CRP). Following the treatment, the Qi-deficient and Yin-deficient groups showed a marked increase in 5-HT levels, restored balance of Glu, GABA, and melatonin, and significant reductions in IL-6 and TNF-α levels. The overall effective rate was 83.5%, with optimal efficacy observed in the Qi-deficient (97.72%) and Yin-deficient (95.34%) groups. Conclusion The novel sleep-aid decoction is effective in treating insomnia in elderly patients, with the best results observed in the Qi-deficient and Yin-deficient constitution groups.
Humans
;
Sleep Initiation and Maintenance Disorders/blood*
;
Aged
;
Male
;
Female
;
Drugs, Chinese Herbal/therapeutic use*
;
Medicine, Chinese Traditional
;
Middle Aged
;
Tumor Necrosis Factor-alpha/blood*
;
Sleep Aids, Pharmaceutical/therapeutic use*
;
Anti-Inflammatory Agents/therapeutic use*
;
Interleukin-6/blood*
;
Interleukin-1beta/blood*
;
Neurotransmitter Agents/blood*
;
Aged, 80 and over
;
C-Reactive Protein/metabolism*
2.Amplification effect of hearing mechanics in unilateral hearing loss.
Quanran LIN ; Kai FANG ; Wendi SHI ; Yuan WANG ; Shihua ZHA ; Yang LI ; Yonghua WANG ; Zhengnong CHEN
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2025;39(3):239-242
Objective:To evaluate the effectiveness of amplification intervention with hearing aids for restoring binaural auditory function in patients with unilateral moderate to severe sensorineural hearing loss. Methods:This study selected 30 patients with normal hearing in one ear and moderate to severe sensorineural hearing loss in the other ear. They were fitted with hearing aids for the worse ear and underwent more than half a year and one year of adaptation training. The Chinese translation of the Twelve-item version of SSQ(C-SSQ12), angle identification test, speech recognition score(SRS) at different signal-to-noise ratios(SNR=5 and SNR=10) and audiometric thresholds were used to compare the results before and after hearing aid use to evaluate the effectiveness of the unilateral hearing loss intervention. Results:The results of the audiometric thresholds, C-SSQ12 scores, angle identification test, and SRS at SNR=5 and SNR=10 in the worse ear of the unilateral hearing loss patients after hearing aid use were all statistically significant compared to before hearing aid use(P<0.01). Conclusion:Amplification intervention with hearing aids has significant effects on restoring binaural auditory function in patients with unilateral moderate to severe sensorineural hearing loss.
Humans
;
Hearing Aids
;
Hearing Loss, Unilateral/therapy*
;
Middle Aged
;
Hearing Loss, Sensorineural/rehabilitation*
;
Adult
;
Female
;
Male
;
Auditory Threshold
;
Young Adult
;
Aged
3.Knowledge, attitudes, and practices towards HIV/AIDS among healthcare workers in a tertiary pediatric government hospital.
Christine Joyce M. HERNANDEZ ; Arlene S. DY-CO
Pediatric Infectious Disease Society of the Philippines Journal 2025;26(2):37-46
BACKGROUND
Human immunodeficiency virus infection and acquired immunodeficiency syndrome are significant public health concerns and social issues. Key players in efforts to stop HIV/AIDS as a public threat are healthcare personnel. Research has shown that negative attitudes of healthcare workers towards HIV can negatively influence their practices and these are associated with their level of knowledge about the disease.
OBJECTIVEThis study aims to investigate the baseline knowledge, attitudes, and practices of healthcare workers towards HIV/AIDS and to determine the association between profession and level of knowledge, attitudes and practices among healthcare workers in a tertiary pediatric government hospital.
METHODOLOGYThis study utilized an analytical cross-sectional research design. Data were collected through a written questionnaire administered to 213 healthcare personnel, who were selected via stratified random sampling from January to April 2024. Knowledge, attitude, and practice (KAP) scores were evaluated using Bloom’s cut-off points. Scores below 60% were classified as low level of knowledge, negative attitude, and poor practice. Scores from 60-79% were classified as moderate level of knowledge, neutral attitude and fair practice. Lastly, scores between 80-100% were classified as high level of knowledge, positive attitude and good practice. Descriptive and inferential statistics, specifically Fisher’s test were used whenever appropriate.
RESULTSAmong 213 study participants, 140 (65.73%) demonstrated a high level of knowledge towards HIV/AIDS among doctors, nurses, medical technologists, and radiologic technologists. There were 161 (75.59%) who exhibited positive attitude towards HIV/AIDS and worked as pharmacists, physical therapists, and dentists. About 154 (72.30%) reported having fair practices on HIV/AIDS.
CONCLUSIONThe healthcare workers in our study have a high level of knowledge, positive attitude, and fair practices towards HIV/AIDS with significant differences between professions. There is a significant association between professions with the level of knowledge, attitudes, and practices towards HIV. Doctors, nurses, medical technologists, and radiologic technologists have higher level of knowledge on HIV/AIDS. Positive attitude was higher among pharmacists, physical therapists, and dentists. Lastly, good practices were highest among midwives.
Human ; Human Immunodeficiency Virus ; Hiv ; Acquired Immunodeficiency Syndrome ; Knowledge ; Attitude ; Healthcare Workers ; Health Personnel
4.A case of nodular secondary syphilis in an HIV-positive 25-year-old Filipino male
Nicole Marie T. Oropeza ; Desiree V. Bautista
Journal of the Philippine Dermatological Society 2024;33(Suppl 1):16-16
Nodular lesions in syphilis are typical of the late benign stage of the disease. It is a rare clinical manifestation of the said disease with a generalized distribution, involving both skin and mucous membranes. Lesions are more prominent on the upper extremities with a special predilection for the palms and the soles in the early stages. We present a case of a 25-year-old Filipino male with a 5-month history of generalized purplish to violaceous nodules with excoriations and scaling. When co-infected with advanced HIV it may present similarly as malignant secondary syphilis. After administration of Benzathine Penicillin G single dose IM, it is important to frequently assess these patients clinically and serologically for possible treatment failures at 3, 6, 9, 12, and 24 months after therapy.
Human ; Male ; Adult: 25-44 Yrs Old ; Aids ; Acquired Immunodeficiency Syndrome ; Hiv
5.Neurocognitive function and its influencing factors in people living with HIV/AIDS.
Qiuling LU ; Qian YE ; Dan CHEN ; Xingli LI
Journal of Central South University(Medical Sciences) 2024;49(12):1902-1908
OBJECTIVES:
The prevalence of human immunodeficiency virus (HIV) associated neurocognitive disorders (HAND) in people living with HIV/acquired immunodeficiency syndrome (PLWHA) worldwide is as high as 42.6%. This study aims to investigate the neurocognitive function status and its influencing factors in PLWHA, providing evidence for early identification and intervention of neurocognitive impairment in this population.
METHODS:
PLWHA aged 18 and above who received outpatient or inpatient care at the First Hospital of Changsha between June and August 2019 were included. Sociodemographic and HIV-related information were collected. Neurocognitive function was assessed using the Brief Neurocognitive Screen (BNCS), which includes the Digit Symbol Test (DST) and Trail Making Test A and B (TMT-A and TMT-B). Impaired neurocognitive function was defined as abnormal scores in at least one dimension (DST score <30, TMT-A time >60 seconds, TMT-B time >90 seconds).
RESULTS:
A total of 375 PLWHA were included, of whom 212 (56.5%) exhibited neurocognitive impairment. Higher impairment rates were observed among females, individuals aged ≥50 years, those with primary education or below, and those who were married/cohabiting (all P<0.05). Heterosexual transmission accounted for the majority of infections (233 cases, 62.1%), with a significantly higher rate of neurocognitive impairment (69.1%) compared to homosexual transmission and unknown routes (P<0.001). Higher WHO clinical stages were associated with increased impairment rates (P<0.001). PLWHA with a nadir CD4+ T cell count <200 cells/mm3 or an infection duration ≥5 years had significantly higher impairment rates than those with higher CD4+ T cell count or shorter infection durations (both P<0.05). Logistic regression analysis showed that patients with a nadir CD4+ T cell count <200 cells/mm3 had a significantly higher risk of neurocognitive impairment (OR=2.461, 95% CI 1.116 to 5.427). Compared to WHO stage I, the risk increased progressively in stage II (OR=6.005, 95% CI 2.906 to 12.407), stage III (OR=6.989, 95% CI 2.502 to 19.523), and stage IV (OR=22.059, 95% CI 7.289 to 66.760; all P<0.05).
CONCLUSIONS
Potential risk factors for neurocognitive impairment in PLWHA include low nadir CD4+ T cell counts and advanced WHO clinical stages. The lower the CD4+ T cell count and the higher the clinical stage, the greater the risk of neurocognitive dysfunction.
Humans
;
Female
;
Male
;
Middle Aged
;
HIV Infections/psychology*
;
Adult
;
Acquired Immunodeficiency Syndrome/psychology*
;
Neuropsychological Tests
;
Cognitive Dysfunction/epidemiology*
;
Neurocognitive Disorders/epidemiology*
;
CD4 Lymphocyte Count
;
Risk Factors
;
Aged
6.Longitudinal analysis of immune reconstitution and metabolic changes in women living with HIV: A real-world observational study.
Xiaolei WANG ; Jiang XIAO ; Leidan ZHANG ; Ying LIU ; Na CHEN ; Meiju DENG ; Chuan SONG ; Tingting LIU ; Yuanyuan ZHANG ; Hongxin ZHAO
Chinese Medical Journal 2023;136(18):2168-2177
BACKGROUND:
Women comprise more than half of people living with human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) worldwide and incomplete immune recovery and metabolic abnormalities affect them deeply. Studies of HIV antiretroviral therapy (ART) have a low female representation in China. We aimed to investigate immune reconstitution and metabolic changes of female HIV-positive cohort in China longitudinally.
METHODS:
HIV-positive women who initiated ART from January 2005 to June 2021 and were followed up regularly at least once a year were included in this study. Immunological indicators (cluster of differentiation 4 [CD4] counts and CD8 counts), viral load (VL), and metabolic indicators were collected at follow-up. All data were collected from the China Disease Prevention and Control Information System (CDPCIS). VL was tested half a year, 1 year after receiving ART, and every other year subsequently according to local policy. CD4/CD8 ratio normalization was considered as the primary outcome and defined as a value ≥1. Incidence rate and probability of CD4/CD8 ratio normalization were estimated through per 100 person-years follow-up (PYFU) and Kaplan-Meier curve, respectively. Multivariate Cox regression was used to identify independent risk factors associated with CD4/CD8 ratio normalization. We further studied the rate of dyslipidemia, hyperuricemia, diabetes, liver injury, and renal injury after ART initiation with the chi-squared tests or Fisher's exact probability tests, and a generalized estimating equation model was used to analyze factors of dyslipidemia and hyperuricemia.
RESULTS:
A total of 494 female patients with HIV/AIDS started ART within 16 years from January 2005 to June 2021, out of which 301 women were enrolled with a median duration of ART for 4.1 years (interquartile range, 2.3-7.0 years). The overall incidence rate of CD4/CD8 ratio normalization was 8.9 (95% confidence interval [CI], 7.4-10.6) per 100 PYFU, and probabilities of CD4/CD8 normalization after initiating ART at 1 year, 2 years, 5 years, and 10 years follow-up were 11.7%, 23.2%, 44.0%, and 59.0%, respectively. Independent risk factors associated with CD4/CD8 normalization were baseline CD4 cell counts <200 cells/μL, CD8 counts >1000 cells/μL, and more than 6 months from the start of combined ART (cART) to first virological suppression. Longitudinally, the rate of hypercholesterolemia (total cholesterol [TC]) and high triglyceride (TG) showed an increasing trend, while the rate of low high-density lipoprotein cholesterol (HDL) showed a decreasing trend. The rate of hyperuricemia presented a downtrend at follow-up. Although liver and renal injury and diabetes persisted during ART, the rate was not statistically significant. Older age and protease inhibitors were independent risk factors for increase of TC and TG, and ART duration was an independent factor for elevation of TC and recovery of HDL-C.
CONCLUSIONS
This study showed that women were more likely to normalize CD4/CD8 ratio in comparison with findings reported in the literature even though immune reconstruction was incomplete.
Humans
;
Female
;
CD4-CD8 Ratio
;
HIV
;
Immune Reconstitution
;
Hyperuricemia/drug therapy*
;
HIV Infections/drug therapy*
;
Acquired Immunodeficiency Syndrome/drug therapy*
;
Anti-Retroviral Agents/therapeutic use*
;
Cholesterol
;
Viral Load
;
CD4 Lymphocyte Count
;
Anti-HIV Agents/therapeutic use*
7.An atlas of immune cell transcriptomes in human immunodeficiency virus-infected immunological non-responders identified marker genes that control viral replication.
Yahong CHEN ; Xin LI ; Shuran LIU ; Wen AO ; Jing LIN ; Zhenting LI ; Shouli WU ; Hanhui YE ; Xiao HAN ; Dongliang LI
Chinese Medical Journal 2023;136(22):2694-2705
BACKGROUND:
Previous studies have examined the bulk transcriptome of peripheral blood immune cells in acquired immunodeficiency syndrome patients experiencing immunological non-responsiveness. This study aimed to investigate the characteristics of specific immune cell subtypes in acquired immunodeficiency syndrome patients who exhibit immunological non-responsiveness.
METHODS:
A single-cell transcriptome sequencing of peripheral blood mononuclear cells obtained from both immunological responders (IRs) (CD4 + T-cell count >500) and immunological non-responders (INRs) (CD4 + T-cell count <300) was conducted. The transcriptomic profiles were used to identify distinct cell subpopulations, marker genes, and differentially expressed genes aiming to uncover potential genetic factors associated with immunological non-responsiveness.
RESULTS:
Among the cellular subpopulations analyzed, the ratios of monocytes, CD16 + monocytes, and exhausted B cells demonstrated the most substantial differences between INRs and IRs, with fold changes of 39.79, 11.08, and 2.71, respectively. In contrast, the CD4 + T cell ratio was significantly decreased (0.39-fold change) in INRs compared with that in IRs. Similarly, the ratios of natural killer cells and terminal effector CD8 + T cells were also lower (0.37-fold and 0.27-fold, respectively) in the INRs group. In addition to several well-characterized immune cell-specific markers, we identified a set of 181 marker genes that were enriched in biological pathways associated with human immunodeficiency virus (HIV) replication. Notably, ISG15 , IFITM3 , PLSCR1 , HLA-DQB1 , CCL3L1 , and DDX5 , which have been demonstrated to influence HIV replication through their interaction with viral proteins, emerged as significant monocyte marker genes. Furthermore, the differentially expressed genes in natural killer cells were also enriched in biological pathways associated with HIV replication.
CONCLUSIONS
We generated an atlas of immune cell transcriptomes in HIV-infected IRs and INRs. Host genes associated with HIV replication were identified as markers of, and were found to be differentially expressed in, different types of immune cells.
Humans
;
Acquired Immunodeficiency Syndrome
;
Transcriptome/genetics*
;
HIV
;
HIV Infections/genetics*
;
Leukocytes, Mononuclear/metabolism*
;
CD4-Positive T-Lymphocytes/metabolism*
;
Virus Replication
;
Membrane Proteins/metabolism*
;
RNA-Binding Proteins/metabolism*
8.Intervention effects of bone conduction hearing aids in patients with single-sided deafness and asymmetric hearing loss.
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2023;37(11):927-933
The incidence of single-sided deafness(SSD) is increasing year by year. Due to the hearing defects of one ear, the ability of sound localization, speech recognition in noise, and quality of life of patients with single-sided deafness will be affected to varying degrees. This article reviews the intervention effects of different types of bone conduction hearing aids in patients with single-sided deafness and asymmetric hearing loss, and the differences of intervention effects between bone conduction hearing aids, contralateral routing of signal(CROS) aids, and cochlea implant(CI), to provide a reference for the auditory intervention and clinical treatment of single-sided deafness and asymmetric hearing loss.
Humans
;
Quality of Life
;
Bone Conduction
;
Hearing Loss, Unilateral/therapy*
;
Speech Perception
;
Hearing Aids
;
Hearing Loss
;
Sound Localization
;
Deafness
;
Treatment Outcome
9.Chinese expert consensus on integrated lipid management in HIV/AIDS.
Chinese Journal of Internal Medicine 2023;62(6):661-672
Human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) are one of the global public health issues concerning health of human beings. Dyslipidemia is one of the major risk factors for cardiovascular events, while elevation of plasma cholesterol levels is associated with the onset of over 50% coronary heart disease. The incidence risks of cardiovascular diseases are higher in HIV/AIDS patients than those in normal populations. In addition to conventional risk factors, viral duplication and suboptimal treatments increase risks of atherosclerotic coronary vascular disease (ASCVD) in HIV/AIDS patients. Thus, a deep knowledge of lipid metabolism and dysregulation profiles, an efficient control of conventional ASCVD risk factors, as well as strengthened measures to lipid management, are of significance to improve long-term prognosis and life quality for HIV/AIDS patients. However, up to date, there is no particular consensus on lipid management for HIV/ADIS populations under long-term antiretroviral therapies (ART). Hereby, based on current status quo of ART in China and frontier achievements of fundamental researches and clinical trials, we invited domestic experts in fields of infectious diseases and cardiovascular diseases to compose this expert consensus on the integrated management of lipid in HIV/AIDS patients in China.
Humans
;
Acquired Immunodeficiency Syndrome
;
Cardiovascular Diseases/prevention & control*
;
Consensus
;
HIV Infections
;
Lipids/blood*
;
China
10.Hemophagocytic Syndrome Secondary to Human Parvovirus B19 Infection in an Acquired Immunodeficiency Syndrome Patient:Report of One Case.
Yan ZHANG ; Jun YAN ; Fei WANG ; Jin GAO ; Kai-Long GU ; Ai-Fang XU
Acta Academiae Medicinae Sinicae 2023;45(3):530-532
The acquired immunodeficiency syndrome patients with compromised immunity are prone to hemophagocytic syndrome secondary to opportunistic infections.This paper reports a rare case of hemophagocytic syndrome secondary to human parvovirus B19 infection in an acquired immunodeficiency syndrome patient,and analyzes the clinical characteristics,aiming to improve the diagnosis and treatment of the disease and prevent missed diagnosis and misdiagnosis.
Humans
;
Lymphohistiocytosis, Hemophagocytic/drug therapy*
;
Erythema Infectiosum/complications*
;
Acquired Immunodeficiency Syndrome/complications*
;
Parvoviridae Infections/diagnosis*
;
Parvovirus B19, Human


Result Analysis
Print
Save
E-mail